Research

Mixed

Bariatric surgery (RYGB, Sleeve Gastrectomy) provides superior and more sustained weight loss (25-35%) and metabolic remission compared to pharmacotherapy, but carries higher surgical risks and potential for long-term complications.

Bariatric surgery (like gastric bypass or sleeve gastrectomy) is the most effective treatment for severe obesity, typically resulting in 25-35% weight loss. It offers significant improvements in diabetes and hypertension. However, it is invasive, carries surgical risks, and requires lifelong nutritional monitoring. It is generally recommended for those with BMI ≥ 40 or ≥ 35 with comorbidities who have not succeeded with other methods.

GoodSupportsHIGH confidence
Bariatric surgery remains the most effective long - term treatment for severe obesity... Roux – en - Y gastric bypass (RYGB) results in greater weight loss compared to sleeve gastrectomy (SG), with approximately 65.7% versus 57.3% weight loss at 5 years... Bariatric surgery tends to produce more consistent and durable results, particularly in individuals with BMI ≥40 kg/m²
Piotr Bartnik et al. · International Journal of Innovative Technologies in Social Science · 2025

Why this rating

Based on meta-analyses and large cohort studies cited.

Source

INNOVATIONS IN OBESITY TREATMENT – GLP – 1 PHARMACOTHERAPY AND BARIATRIC SURGERY

Piotr Bartnik et al. · International Journal of Innovative Technologies in Social Science · 2025

DOI 10.31435/ijitss.3(47).2025.3682

narrative_review
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →